AI-generated summary
The authors report a randomized split-face, investigator-blinded trial of a 1450 nm laser in 38 people with moderate to severe acne, of whom 32 completed the primary outcome. Treated and control sides of the face showed similar reductions in inflammatory lesion count and acne grade at four weeks after the third treatment, and the difference persisted at 12 months in 23 participants. Treatment was described as well tolerated.
- Participants
- 38
- Who or what was studied
- People over 16 years of age with moderate to severe inflammatory acne vulgaris recruited from a secondary care dermatology department
- Wavelengths
- 1450 nm
- Limits stated in the abstract
- The abstract notes that 6 of 38 participants did not complete the primary outcome and only 23 were assessed at 12 months, and that a systemic effect of the laser is possible.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 450 nm, 1450 nm
- Total energy
- 9 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, GRADE, Primary outcome, Confidence interval, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.